Drugs / DS-9231
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03316729 | Jan 2018 → Feb 2020 | pulmonary embolism | Daiichi Sankyo | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-9231 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03316729 ↗ |
| Route | Intravenous | “intravenous infusion” NCT03316729 ↗ |